Assyro AI

Orange Book product · Generic (ANDA)

MOEXIPRIL HYDROCHLORIDE

MOEXIPRIL HYDROCHLORIDE

Generic (ANDA)ANDA 076204TE ABRX TEVA

At a glance

May 08, 2003

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 08, 2003

    23 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

MOEXIPRIL HYDROCHLORIDE

Strength

7.5MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 076204

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MOEXIPRIL HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.